97-4513. Oral Dosage Form New Animal Drugs; Lufenuron Suspension and Tablets  

  • [Federal Register Volume 62, Number 37 (Tuesday, February 25, 1997)]
    [Rules and Regulations]
    [Page 8371]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-4513]
    
    
    -----------------------------------------------------------------------
    
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    21 CFR Part 520
    
    
    Oral Dosage Form New Animal Drugs; Lufenuron Suspension and 
    Tablets
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is amending the animal 
    drug regulations to reflect approval of two supplemental new animal 
    drug applications (NADA's) filed by Ciba-Geigy Animal Health, Ciba-
    Geigy Corp. The supplements provide that veterinary prescriptions are 
    no longer required for use of lufenuron tablets for dogs and oral 
    suspension for cats.
    
    EFFECTIVE DATE: February 25, 1997.
    
    FOR FURTHER INFORMATION CONTACT: Marcia K. Larkins, Center for 
    Veterinary Medicine (HFV-112), Food and Drug Administration, 7500 
    Standish P1., Rockville, MD 20855, 301-594-0614.
    
    SUPPLEMENTARY INFORMATION: Ciba-Geigy Animal Health, Ciba-Geigy Corp., 
    P.O. Box 18300, Greensboro, NC 27419-8300, filed supplemental NADA 141-
    026 that provides for oral administration of Program 
    (lufenuron) suspension for cats and kittens for control of flea 
    populations and supplemental NADA 141-035 that provides for oral 
    administration of Program (lufenuron) tablets for dogs and 
    puppies for prevention and control of flea populations. The 
    supplemental NADA's provide that veterinary prescriptions are no longer 
    required. The supplemental NADA's are approved as of December 31, 1996, 
    and the regulations are amended by revising 21 CFR 520.1288(c)(3) and 
    520.1289(c)(3) to remove the limitation for veterinary prescription 
    use.
        In accordance with the freedom of information provisions of 21 CFR 
    part 20 and 514.11(e)(2)(ii), a summary of safety and effectiveness 
    data and information submitted to support approval of this application 
    may be seen in the Dockets Management Branch (HFA-305), Food and Drug 
    Administration, 12420 Parklawn Dr., rm. 1-23, Rockville, MD 20857, 
    between 9 a.m. and 4 p.m., Monday through Friday.
        The agency has carefully considered the potential environmental 
    effects of this action. FDA has concluded that the action will not have 
    a significant impact on the human environment, and that an 
    environmental impact statement is not required. The agency's finding of 
    no significant impact and the evidence supporting that finding, 
    contained in an environmental assessment, may be seen in the Dockets 
    Management Branch (address above) between 9 a.m. and 4 p.m., Monday 
    through Friday.
    
    List of Subjects in 21 CFR Part 520
    
        Animal drugs.
        Therefore, under the Federal Food, Drug, and Cosmetic Act and under 
    authority delegated to the Commissioner of Food and Drugs and 
    redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is 
    amended as follows:
    
    PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS
    
        1. The authority citation for 21 CFR part 520 continues to read as 
    follows:
    
        Authority: Sec. 512 of the Federal Food, Drug, and Cosmetic Act 
    (21 U.S.C. 360b).
    
    Sec. 520.1288  [Amended]
    
        2. Section 520.1288 Lufenuron tablets is amended in paragraph 
    (c)(3) by removing the last sentence.
    
    Sec. 520.1289  [Amended]
    
        3. Section 520.1289 Lufenuron suspension is amended in paragraph 
    (c)(3) by removing the last sentence.
    
    
        Dated: February 3, 1997.
    Stephen F. Sundlof,
    Director, Center for Veterinary Medicine.
    [FR Doc. 97-4513 Filed 2-24-97; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
2/25/1997
Published:
02/25/1997
Department:
Health and Human Services Department
Entry Type:
Rule
Action:
Final rule.
Document Number:
97-4513
Dates:
February 25, 1997.
Pages:
8371-8371 (1 pages)
PDF File:
97-4513.pdf
CFR: (2)
21 CFR 520.1288
21 CFR 520.1289